Guiling Li
- Biochemistry top 10%
- Pharmaceutical Science top 5%
- Molecular Biology
- Pharmacology top 10%
- Biomaterials
- Topics
- Liver physiology and pathology (7 papers)Liver Disease Diagnosis and Treatment (7 papers)Advancements in Transdermal Drug Delivery (2 papers)
- Journals
- ACS NanoInternational Journal of Molecular SciencesJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- ChinaUnited States
In The Last Decade
Guiling Li
15 papers receiving 327 citations
Peers
Comparison fields: 5 of 87
- Biochemistry 74
- Pharmaceutical Science 68
- Molecular Biology 61
- Pharmacology 58
- Biomaterials 42
Countries citing papers authored by Guiling Li
This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).
Fields of papers citing papers by Guiling Li
This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.
Co-authorship network of co-authors of Guiling Li
This figure shows the co-authorship network connecting the top 25 collaborators of Guiling Li. A scholar is included among the top collaborators of Guiling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiling Li. Guiling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 20 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 11 | |
| 7 | 13 | |
| 8 | 16 | |
| 9 | 14 | |
| 10 | 12 | |
| 11 | 11 | |
| 12 | 29 | |
| 13 | 32 | |
| 14 | 41 | |
| 15 | 31 | |
| 16 | 88 |
About Guiling Li
Guiling Li is a scholar working on Hepatology, Pharmacology and Pharmaceutical Science, having authored 16 papers that have together received 333 indexed citations. Recurring topics across this work include Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (68 citations), Biochemistry (74 citations) and Pharmacology (58 citations). Guiling Li has collaborated with scholars based in China and United States. Frequent co-authors include Xinru Li, Mei Li, Yating Fan, Reem H. Elbekai, Darryl C. Zeldin, Matthew L. Edin, Jun Wu, Ding Ma, Dao Wen Wang and Yanfang Li. Their work appears in journals such as ACS Nano, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.